F.L. Putnam Investment Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

F.L. Putnam Investment Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.14M	Buy	13,537 +20	+0.1%	+$2.7K	0.03%	281
2026 Q1	$1.73M	Sell	13,517 -189	-1%	-$23.6K	0.03%	276
2025 Q4	$1.67M	Sell	13,706 -2,609	-16%	-$299K	0.02%	273
2025 Q3	$1.63M	Sell	16,315 -4,033	-20%	-$363K	0.02%	279
2025 Q2	$1.69M	Sell	20,348 -2,013	-9%	-$161K	0.03%	262
2025 Q1	$1.81M	Sell	22,361 -17,752	-44%	-$1.59M	0.03%	250
2024 Q4	$3.61M	Buy	40,113 +18,555	+86%	+$1.8M	0.07%	187
2024 Q3	$2.13M	Buy	21,558 +2,825	+15%	+$278K	0.04%	242
2024 Q2	$1.74M	Buy	18,733 +1,099	+6%	+$98.5K	0.03%	258
2024 Q1	$1.67M	Buy	+17,634	New	+$1.64M	0.04%	218
2021 Q4	–	Sell	-1,855	Closed	-$233K	–	420
2021 Q3	$233K	Sell	1,855 -478	-20%	-$61.6K	0.01%	376
2021 Q2	$316K	Sell	2,333 -1,212	-34%	-$159K	0.01%	337
2021 Q1	$481K	Sell	3,545 -10	-0.3%	-$1.5K	0.02%	253
2020 Q4	$500K	Sell	3,555 -5	-0.1%	-$640	0.02%	227
2020 Q3	$397K	Sell	3,560 -25	-0.7%	-$2.8K	0.02%	223
2020 Q2	$401K	Sell	3,585 -304	-8%	-$29.9K	0.02%	222
2020 Q1	$301K	Sell	3,889 -1,535	-28%	-$136K	0.02%	234
2019 Q4	$516K	Hold	5,424	–	–	0.03%	214
2019 Q3	$414K	Buy	5,424 +3,579	+194%	+$297K	0.03%	209
2019 Q2	$162K	Buy	+1,845	New	+$157K	0.01%	231
2018 Q4	–	Sell	-2,694	Closed	-$258K	–	233
2018 Q3	$258K	Sell	2,694 -100	-4%	-$9.7K	0.02%	199
2018 Q2	$266K	Sell	2,794 -345	-11%	-$31.7K	0.03%	192
2018 Q1	$275K	Sell	3,139 -106	-3%	-$9.68K	0.03%	210
2017 Q4	$275K	Sell	3,245 -320	-9%	-$26.8K	0.03%	199
2017 Q3	$309K	Buy	+3,565	New	+$286K	0.03%	190
2017 Q1	$266K	Hold	3,835	–	–	0.03%	195
2016 Q4	$227K	Sell	3,835 -1,015	-21%	-$62.7K	0.03%	190
2016 Q3	$322K	Hold	4,850	–	–	0.04%	162
2016 Q2	$262K	Buy	+4,850	New	+$266K	0.03%	155
2016 Q1	–	Sell	-16,689	Closed	-$1.17M	–	177
2015 Q4	$1.17M	Sell	16,689 -10,833	-39%	-$739K	0.14%	108
2015 Q3	$1.71M	Sell	27,522 -1,323	-5%	-$104K	0.21%	89
2015 Q2	$2.42M	Sell	28,845 -450	-2%	-$35K	0.27%	81
2015 Q1	$2.2M	Sell	29,295 -7,806	-21%	-$545K	0.25%	84
2014 Q4	$2.31M	Sell	37,101 -786	-2%	-$44.8K	0.27%	84
2014 Q3	$1.97M	Sell	37,887 -540	-1%	-$27.5K	0.23%	95
2014 Q2	$1.97M	Sell	38,427 -20,109	-34%	-$907K	0.23%	100
2014 Q1	$2.78M	Sell	58,536 -4,743	-7%	-$243K	0.33%	90
2013 Q4	$2.75M	Sell	63,279 -3,978	-6%	-$165K	0.33%	90
2013 Q3	$2.9M	Buy	+67,257	New	+$2.72M	0.39%	83

Other funds holding XBI

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

MIH

Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return

MSR

Main Street Research Lakeville, Connecticut $2.12B AUM 67.44% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

Whittier Trust South Pasadena, California $10.2B AUM 33.39% 1-Year Est. Return

F.L. Putnam Investment Management's XBI Position: Q2 2026 in Review

F.L. Putnam Investment Management increased its State Street SPDR S&P Biotech ETF (XBI) stake by 0.15% in Q2 2026, buying an estimated $2.7K and bringing the position to 13,537 shares worth $2.14M. The position accounts for 0.03% of the portfolio, ranked #281.

F.L. Putnam Investment Management first reported a position in XBI in Q3 2013 and has held it in 39 quarters since. The position peaked at $3.61M in Q4 2024. 595 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

F.L. Putnam Investment Management held 13,537 shares of State Street SPDR S&P Biotech ETF worth $2.14M as of Q2 2026.
F.L. Putnam Investment Management bought 20 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $2.7K.
State Street SPDR S&P Biotech ETF made up 0.03% of F.L. Putnam Investment Management's portfolio in Q2 2026, its #281 holding.
F.L. Putnam Investment Management first reported a position in State Street SPDR S&P Biotech ETF in Q3 2013 and has held it in 39 quarters since.
F.L. Putnam Investment Management's State Street SPDR S&P Biotech ETF position peaked at $3.61M in Q4 2024.
595 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on F.L. Putnam Investment Management's 13F filing for Q2 2026, filed 6 Aug 2026.